Fingolimod and Lorazepam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fingolimod (fingolimod) and Lorazepam (lorazepam). Common drug interactions include fatigue among females and foetal exposure during pregnancy among males.

The phase IV clinical study analyzes what interactions people have when they take Fingolimod and Lorazepam. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Fingolimod?

Fingolimod has active ingredients of fingolimod. eHealthMe is studying from 5,150 Fingolimod users. Check the latest studies of Fingolimod.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.



On Jul, 09, 2026

27 people who take Fingolimod and Lorazepam together, and have interactions are studied.

Fingolimod and Lorazepam drug interactions.

What are the common drug interactions of Fingolimod and Lorazepam, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Headache (pain in head)
  3. Blood pressure increased
  4. Cough
  5. Cystitis (inflammation of the wall of the bladder)
  6. Diarrhoea
  7. Dyspnoea (difficult or laboured respiration)
  8. Eye disorder
  9. Influenza
  10. Panic attack

male:

  1. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Headache (pain in head)
  4. Hypotension (abnormally low blood pressure)
  5. Incontinence (lack of moderation or self-control)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  8. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  9. Pain
  10. Renal failure acute (rapid kidney dysfunction)

What are the common drug interactions of Fingolimod and Lorazepam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Encephalitis autoimmune (autoimmune origin disturbances of consciousness and pyramidal signs, inflammation of the brain)
  2. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  3. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  4. Postictal state
  5. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
  6. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
  7. Substance abuse

30-39:

  1. Abdominal pain
  2. Abdominal pain upper
  3. Arthralgia (joint pain)
  4. Asthenia (weakness)
  5. Chest pain
  6. Dizziness
  7. Electrocardiogram st segment elevation
  8. Fatigue (feeling of tiredness)
  9. Headache (pain in head)
  10. Hypertension (high blood pressure)

40-49:

  1. Multiple-drug resistance
  2. White blood cell count decreased

50-59:

  1. Fatigue (feeling of tiredness)
  2. Headache (pain in head)
  3. Pneumonia
  4. Abdominal discomfort
  5. Pain
  6. Pseudomonas test positive
  7. Urinary tract infection
  8. Urinary tract infection pseudomonal

60+:

  1. Blood pressure increased
  2. Cough
  3. Abasia (inability to walk)
  4. Atrioventricular block first degree (heart block first degree)
  5. Balance disorder
  6. Basilar migraine (migraine with neurological symptoms related to the brain stem or with neurological symptoms on both sides of the body)
  7. Blood pressure decreased
  8. Bradycardia (abnormally slow heart action)
  9. Chills (felling of cold)
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 14 people, 51.85%
  2. Depression: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Fingolimod and Lorazepam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fingolimod and Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fingolimod:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fingolimod and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lorazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on fingolimod and lorazepam (the active ingredients of Fingolimod and Lorazepam, respectively), and Fingolimod and Lorazepam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: